| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 25.06. | CPH Group AG startet neue Ära nach erfolgreicher Abspaltung des Papiergeschäfts | 101 | EQS Group (DE) | • Die Trennung des Papierbereichs von den Chemie- und Verpackungsaktivitäten ist erfolgreich abgeschlossen
• Die neu firmierte CPH Group AG strebt weiteres organisches und anorganisches Wachstum an
•... ► Artikel lesen | |
| 25.06. | Fragbite Group AB: Bulletin from the Extraordinary General Meeting in Fragbite Group AB (publ) | 71 | GlobeNewswire (Europe) | Fragbite Group AB (publ) ("Fragbite Group" or "the Company") has today, 25 June 2024, held an Extraordinary General Meeting (the "EGM"). The EGM resolved to approve the Board of Directors' proposal... ► Artikel lesen | |
| 25.06. | PEXA GROUP LIMITED: PEXA Group Response to ARNECC Ministerial Forum | - | ASX | ||
| 25.06. | BHG Group AB: BHG significantly reduces warehouse space after consolidation and successful reduction of inventory and writes down parts of inventory | 106 | GlobeNewswire (Europe) | Consolidations and substantially decreased inventory levels enable BHG Group ("BHG") to reduce warehouse space, which is expected to lead to reduced rent costs of approximately SEK 38 million on an... ► Artikel lesen | |
| 25.06. | Substrate Artificial - Notice of Extraordinary General Meeting | - | RNS | ||
| 25.06. | Appili Therapeutics Inc.: Appili Therapeutics Reports Fiscal Year 2024 Financial and Operational Results | 256 | GlobeNewswire (Europe) | LIKMEZ (ATI-1501) for Metronidazole Oral Suspension 500mg/5mL launched and commercial sales ongoing Funding commitments from U.S. Air Force Academy intended to advance ATI-1701 toward an IND submission... ► Artikel lesen | |
| 25.06. | Base Carbon Inc.: Base Carbon Announces Annual General and Special Meeting Results | 84 | GlobeNewswire (Europe) | TORONTO, June 25, 2024 (GLOBE NEWSWIRE) -- Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (together, with affiliates... ► Artikel lesen | |
| 25.06. | Lifeist Wellness Inc. Signs Agreements with Simply Solventless Concentrates Ltd. | 143 | GlobeNewswire (Europe) | TORONTO, June 25, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. ("Lifeist" or the "Company") (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science... ► Artikel lesen | |
| 25.06. | Twelve Seas Investment Company II Announces Termination of its Business Combination Agreement with Crystal Lagoons, Expected Filing of Form 25 and Final Redemption Amount | 96 | GlobeNewswire (Europe) | New York, NY, June 25, 2024 (GLOBE NEWSWIRE) -- Twelve Seas Investment Company II (the "Company") today announced that its previously announced Agreement and Plan of Merger in connection with its... ► Artikel lesen | |
| 25.06. | Annexon Biosciences: Annexon Presented Additional Positive Phase 3 Results for ANX005 C1q-Targeted Immunotherapy in Guillain-Barré Syndrome at the 2024 PNS Annual Meeting | 133 | GlobeNewswire (Europe) | ANX005-Treated Patients Demonstrated Faster and More Complete Recovery from Week 1 through Week 26 on Primary and Multiple Pre-Specified Endpoints Two and a Half Times More ANX005-Treated Patients... ► Artikel lesen | |
| 25.06. | FLINT Corp.: FLINT Announces Voting Results from Shareholders' Meeting | 62 | GlobeNewswire (Europe) | CALGARY, Alberta, June 25, 2024 (GLOBE NEWSWIRE) -- FLINT Corp. ("FLINT") (TSX: FLNT) is pleased to announce that all matters presented for approval at its annual and special meeting (the "Meeting")... ► Artikel lesen | |
| 25.06. | Fennec Pharmaceuticals Inc.: Fennec Announces Results of Annual Meeting | 84 | GlobeNewswire (Europe) | RESEARCH TRIANGLE PARK, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (the "Company") (NASDAQ:FENC) (TSX:FRX) today announced that the nominees listed in the management proxy... ► Artikel lesen | |
| 25.06. | Worthington Enterprises, Inc.: Worthington Enterprises Reports Fourth Quarter Fiscal 2024 Results | 395 | GlobeNewswire (Europe) | COLUMBUS, Ohio, June 25, 2024 (GLOBE NEWSWIRE) -- Worthington Enterprises, Inc. (NYSE: WOR) reported net sales of $318.8 million and a net loss from continuing operations of $31.5 million, or $(0.64)... ► Artikel lesen | |
| 25.06. | Progress Software Corporation: Progress Announces Second Quarter 2024 Financial Results | 104 | GlobeNewswire (Europe) | Second Quarter Revenues and Earnings Per Share Ahead of GuidanceRaising Full Year Revenue and Earnings Per Share Outlook BURLINGTON, Mass., June 25, 2024 (GLOBE NEWSWIRE) -- Progress (Nasdaq: PRGS)... ► Artikel lesen | |
| 25.06. | Methode Electronics, Inc.: Methode Electronics Appoints Jon DeGaynor as President and CEO | 287 | GlobeNewswire (Europe) | Methode Electronics to Announce Fourth Quarter Fiscal 2024 Results on Thursday, July 11, 2024 Seasoned CEO Brings Deep Experience in Engineered Products and Track Record of Driving Successful Strategic... ► Artikel lesen | |
| 25.06. | Tecnoglass Inc.: Tecnoglass Board of Directors Announces Review of Strategic Alternatives | 220 | GlobeNewswire (Europe) |
- Reiterates Full Year 2024 Outlook - Miami, FL, June 25, 2024 (GLOBE NEWSWIRE) -- Tecnoglass, Inc. (NYSE: TGLS) ("Tecnoglass" or the "Company"), a leading producer of high-end aluminum and vinyl... ► Artikel lesen | |
| 25.06. | Allakos Inc.: Allakos Announces Positive Results from its Ongoing Phase 1 Trial of AK006 in Healthy Volunteers, with AK006 Demonstrating High Receptor Occupancy on Mast Cells and a Favorable Safety Profile | 162 | GlobeNewswire (Europe) | - AK006 achieved serum concentrations consistent with levels demonstrating inhibitory activity in preclinical experiments -- Skin biopsies from subjects treated with AK006 show high receptor occupancy... ► Artikel lesen | |
| 25.06. | Intellia Therapeutics, Inc.: Intellia Announces Positive Clinical Proof-of-Concept Data for Redosing a CRISPR-Based Therapy with its Proprietary LNP-Based Delivery Platform | 82 | GlobeNewswire (Europe) | First-ever clinical data demonstrating redosing with an investigational in vivo CRISPR-based therapyFollow-on dosing with a 55 mg dose of NTLA-2001 led to a 90% median reduction in serum TTR at day... ► Artikel lesen | |
| 25.06. | Automotive Finco Corp. Announces Results of Shareholders' Meeting | 120 | GlobeNewswire (Europe) | Not for distribution to United States newswire services or for dissemination in the United States. This news release does not constitute an offer to sell or a solicitation of an offer to buy any... ► Artikel lesen | |
| 25.06. | Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion | 124 | GlobeNewswire (Europe) | Company announcement - No. 34 / 2024 Zealand Pharma announces upsizing of previously announced equity offering from approximately USD 900 million / DKK 6.257 billion to USD 1 billion / DKK 7 billion... ► Artikel lesen |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 450 |
| VOLKSWAGEN | 228 |
| EVOTEC | 184 |
| BAYER | 170 |
| INTEL | 134 |
| SUPER MICRO COMPUTER | 130 |
| THYSSENKRUPP | 128 |
| TESLA | 127 |
| PALANTIR TECHNOLOGIES | 119 |
| TUI | 115 |
| RHEINMETALL | 95 |
| BYD | 85 |
| AIXTRON SE | 82 |
| AMAZON | 79 |
| BASF | 78 |
| DEUTSCHE BANK | 78 |
| COMMERZBANK | 74 |
| NEL | 74 |
| PLUG POWER | 74 |
| BROADCOM | 73 |
| MERCEDES-BENZ | 73 |
| PAYPAL | 68 |
| ALLIANZ | 61 |
| BIONTECH | 59 |
| DEUTSCHE LUFTHANSA | 59 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
